Clinical Cancer Research, Vol 2, Issue 1 137-145, Copyright © 1996 by American Association for Cancer Research

ARTICLES

Aneusomies of chromosomes 8 and Y detected by fluorescence in situ hybridization are prognostic markers for pathological stage C (pt3N0M0) prostate carcinoma

S Takahashi, A Alcaraz, JA Brown, TJ Borell, JF Herath, EJ Bergstralh, MM Lieber and RB Jenkins
Department of Urology and Laboratory Medicine and Pathology and Section of Biostatistics, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA.

In an attempt to identify new prognostic markers, we performed fluorescence in situ hybridization (FISH) ploidy analysis of tumor tissue from patients with a targeted stage and histological grade of prostate carcinoma. We identified all 227 patients from the Mayo Clinic radical prostatectomy data base who had a high histological grade pathological stage C (pT3N0M0) tumor removed between 1966 and 1987. After histological review of the paraffin-embedded specimen blocks, 181 cases were suitable for FISH analysis using chromosome enumeration probes for chromosomes 7, 8, 10, 12, X, and Y. FISH detected 80 (44%) diploid, 22 (12%) tetraploid, and 79 (44%) aneuploid tumors. The common aneusomies were of chromosomes 7 and 8, which were present in 51 (28%) and 46 (25%) tumors, respectively. Aneusomies of chromosomes 10, 12, X, and Y were observed in 11 (6%), 15 (8%) 12 (7%) and 16 (9%) tumors, respectively. FISH aneuploid tumors showed a trend of more frequent systemic prostate cancer progression than nonaneuploid tumors (P = 0.060). For individual chromosome anomalies, gains of chromosome 8, aneusomy of chromosome 8, and aneusomy of chromosome Y correlated highly with systemic cancer progression (P = 0.006, 0.013, and 0.021, respectively). Gains of chromosome Y and aneusomy of chromosome Y were associated with an increased prostate cancer death rate (P < 0.001 for both). Multivariate analysis showed that gains of chromosome 8 and aneusomy of chromosome Y were significant independent "predictors" of systemic cancer progression (P = 0.008) and cancer death (P < 0.001), respectively. These results demonstrate that aneuploidy and specific aneusomies detected by FISH are potential markers for a poor prognosis in histological high-grade pathological stage C (pT3N0M0) prostate carcinoma.

This article has been cited by other articles:

				D. Furlan, B. Bernasconi, S. Uccella, R. Cerutti, I. Carnevali, and C. Capella Allelotypes and Fluorescence In situ Hybridization Profiles of Poorly Differentiated Endocrine Carcinomas of Different Sites Clin. Cancer Res., March 1, 2005; 11(5): 1765 - 1775. [Abstract] [Full Text] [PDF]

				M Maillard, B Cadot, R Y Ball, K Sethia, D R Edwards, B Perbal, and R Tatoud Differential expression of the ccn3 (nov) proto-oncogene in human prostate cell lines and tissues Mol. Pathol., August 1, 2001; 54(4): 275 - 280. [Abstract] [Full Text] [PDF]

				R. Shah, N. R. Mucci, A. Amin, J. A. Macoska, and M. A. Rubin Postatrophic Hyperplasia of the Prostate Gland : Neoplastic Precursor or Innocent Bystander? Am. J. Pathol., May 1, 2001; 158(5): 1767 - 1773. [Abstract] [Full Text] [PDF]